Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parul Grover

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry|July 18, 2025
Drug-Resistant Infections: A Global Challenge for the FutureParul Grover
CNS & Neurological Disorders Drug Targets|November 6, 2024
Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B InhibitorsNeha Rana, Parul Grover
Journal of Pharmaceutical and Biomedical Analysis|September 12, 2021
LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathwayParul Grover, Monika Bhardwaj, Lovekesh Mehta
Journal of Pharmaceutical and Biomedical Analysis|September 20, 2022
Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMRParul Grover, Monika Bhardwaj, Debaraj Mukherjee
Current Topics in Medicinal Chemistry|January 30, 2024
Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug DiscoveryNeha Rana, Parul Grover, Hridayanand Singh
Journal of Chromatographic Science|April 18, 2023
Development and Validation of Robust, Highly Sensitive and Stability-Indicating RP-HPLC Method for Estimation of Deferasirox and its Degradation ProductsTarun Shishodia, Parul Grover, K Nagarajan, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 6, 2020
LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathwayLovekesh Mehta, Tanveer Naved, Parul Grover, et al.
Journal of Chromatographic Science|May 4, 2024
Development and Validation of Fast and Sensitive RP-HPLC Stability-Indicating Method for Quantification of Piroxicam in Bulk DrugVikas Chauhan, Parul Grover, Monika Bhardwaj, et al.
Current Topics in Medicinal Chemistry|April 11, 2023
Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future PerspectiveParul Grover, Suman Rohilla, Monika Bhardwaj, et al.
3 Biotech|January 30, 2023
Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosisDeepti Katiyar, Shipra Singhal, Priya Bansal, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|July 18, 2025
Drug-Resistant Infections: A Global Challenge for the FutureParul Grover
CNS & Neurological Disorders Drug Targets|November 6, 2024
Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B InhibitorsNeha Rana, Parul Grover
Journal of Pharmaceutical and Biomedical Analysis|September 12, 2021
LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathwayParul Grover, Monika Bhardwaj, Lovekesh Mehta
Journal of Pharmaceutical and Biomedical Analysis|September 20, 2022
Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMRParul Grover, Monika Bhardwaj, Debaraj Mukherjee
Current Topics in Medicinal Chemistry|January 30, 2024
Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug DiscoveryNeha Rana, Parul Grover, Hridayanand Singh
Journal of Chromatographic Science|April 18, 2023
Development and Validation of Robust, Highly Sensitive and Stability-Indicating RP-HPLC Method for Estimation of Deferasirox and its Degradation ProductsTarun Shishodia, Parul Grover, K Nagarajan, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 6, 2020
LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathwayLovekesh Mehta, Tanveer Naved, Parul Grover, et al.
Journal of Chromatographic Science|May 4, 2024
Development and Validation of Fast and Sensitive RP-HPLC Stability-Indicating Method for Quantification of Piroxicam in Bulk DrugVikas Chauhan, Parul Grover, Monika Bhardwaj, et al.
Current Topics in Medicinal Chemistry|April 11, 2023
Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future PerspectiveParul Grover, Suman Rohilla, Monika Bhardwaj, et al.
3 Biotech|January 30, 2023
Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosisDeepti Katiyar, Shipra Singhal, Priya Bansal, et al.
Pageof 3